NYSE: ADCT
Adc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?

Insider buying vs selling

Have Adc Therapeutics Sa insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter HugDirector2026-06-032,156$3.08
$6.64kSell
Jeanpierre BizzariDirector2026-06-0312,600$3.08
$38.81kSell
Robert AzelbyDirector2026-06-0312,600$3.08
$38.81kSell
Viviane MongesDirector2026-06-032,596$3.08
$8.00kSell
Ron SquarerDirector2026-06-0315,196$3.08
$46.80kSell
Timothy CoughlinDirector2026-06-0312,600$3.08
$38.81kSell
Victor SandorDirector2026-06-0312,600$3.08
$38.81kSell
Redmile Group LLC10% Owner2026-04-022,529,491$3.28
$8.29MSell
Redmile Group LLC10% Owner2026-04-022,634,506$3.28
$8.64MSell
Redmile Group LLC10% Owner2026-04-01162,517$3.80
$617.40kSell

1 of 3

ADCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADCT insiders and whales buy or sell their stock.

ADCT Shareholders

What type of owners hold Adc Therapeutics Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC30.23%38,598,759$47.48MInsider
Hans Peter Wild7.67%9,788,944$12.04MInsider
Ameet Mallik2.19%2,790,870$3.43MInsider
Jose Carmona0.73%938,076$1.15MInsider
Mohamed Zaki0.70%896,317$1.10MInsider
Peter J. Graham0.66%841,640$1.04MInsider
Thomas Pfisterer0.49%625,755$769.68kInsider
Peter Hug0.21%263,344$323.91kInsider
Viviane Monges0.15%186,447$229.33kInsider
Victor Sandor0.11%140,686$173.04kInsider

1 of 3

ADCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADCT0.06%43.59%Net Selling
MENS0.00%33.35%
NBP0.01%12.16%Net BuyingNet Selling
IPHA0.00%0.00%
CDXS0.06%67.55%Net Selling

Adc Therapeutics Sa Stock Ownership FAQ

Who owns Adc Therapeutics Sa?

Adc Therapeutics Sa (NYSE: ADCT) is owned by 0.06% institutional shareholders, 43.59% Adc Therapeutics Sa insiders, and 56.35% retail investors. Redmile Group LLC is the largest individual Adc Therapeutics Sa shareholder, owning 38.60M shares representing 30.23% of the company. Redmile Group LLC's Adc Therapeutics Sa shares are currently valued at $47.09M.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.